Question 1

What are the potential side effects of HRS-6209 and the other medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Trial of HRS-6209 in Combination With Other Antitumor Therapies in Breast Cancer Patients or HRS-9813 as Monotherapy in Patients With Advanced Solid Tumors clinical trial (NCT06555068). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Trial of HRS-6209 in Combination With Other Antitumor Therapies in Breast Cancer Patients or HRS-9813 as Monotherapy in Patients With Advanced Solid Tumors clinical trial (NCT06555068). Contact the study team or your healthcare provider for specific answers.

Question 3

What will my treatment schedule look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Trial of HRS-6209 in Combination With Other Antitumor Therapies in Breast Cancer Patients or HRS-9813 as Monotherapy in Patients With Advanced Solid Tumors clinical trial (NCT06555068). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific tests or procedures I will need to undergo during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Trial of HRS-6209 in Combination With Other Antitumor Therapies in Breast Cancer Patients or HRS-9813 as Monotherapy in Patients With Advanced Solid Tumors clinical trial (NCT06555068). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my health be monitored throughout the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Trial of HRS-6209 in Combination With Other Antitumor Therapies in Breast Cancer Patients or HRS-9813 as Monotherapy in Patients With Advanced Solid Tumors clinical trial (NCT06555068). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience severe side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Trial of HRS-6209 in Combination With Other Antitumor Therapies in Breast Cancer Patients or HRS-9813 as Monotherapy in Patients With Advanced Solid Tumors clinical trial (NCT06555068). Contact the study team or your healthcare provider for specific answers.

What this study is about